These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26996982)

  • 21. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
    Wang Y; Yeo QQ; Ko Y
    Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the ability to self-manage diabetes for adults living with type 1 or 2 diabetes.
    Wilkinson A; Whitehead L; Ritchie L
    Int J Nurs Stud; 2014 Jan; 51(1):111-22. PubMed ID: 23473390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes in people with an intellectual disability: a systematic review of prevalence, incidence and impact.
    McVilly K; McGillivray J; Curtis A; Lehmann J; Morrish L; Speight J
    Diabet Med; 2014 Aug; 31(8):897-904. PubMed ID: 24824086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial.
    Odnoletkova I; Buysse H; Nobels F; Goderis G; Aertgeerts B; Annemans L; Ramaekers D
    BMC Med Inform Decis Mak; 2016 Nov; 16(1):142. PubMed ID: 27825340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes.
    Kovacs Burns K; Nicolucci A; Holt RI; Willaing I; Hermanns N; Kalra S; Wens J; Pouwer F; Skovlund SE; Peyrot M;
    Diabet Med; 2013 Jul; 30(7):778-88. PubMed ID: 23701236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes management: current diagnostic criteria, drug therapies, and state legislation.
    Lyons T; Gourley G; Holt JM
    Am J Manag Care; 1997 Oct; 3(10):1599-608; quiz 1161-4. PubMed ID: 10178463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    Uchendu C; Blake H
    Diabet Med; 2017 Mar; 34(3):328-339. PubMed ID: 27472405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reasons why people do not attend NHS Health Checks: a systematic review and qualitative synthesis.
    Harte E; MacLure C; Martin A; Saunders CL; Meads C; Walter FM; Griffin SJ; Mant J; Usher-Smith JA
    Br J Gen Pract; 2018 Jan; 68(666):e28-e35. PubMed ID: 29203682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes.
    Matteucci E; Giampietro O
    Diabetes Nutr Metab; 2003; 16(5-6):298-305. PubMed ID: 15000441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor.
    Long Q; He M; Tang X; Allotey P; Tang S
    Diabet Med; 2017 Jan; 34(1):120-126. PubMed ID: 27472098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovative approaches to reduce diabetes costs.
    Reese AB
    N C Med J; 2011; 72(5):409-12. PubMed ID: 22416528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Technology and the Human Factor.
    Liberman A; Drobnic Radobuljac M
    Diabetes Technol Ther; 2017 Feb; 19(S1):S120-S127. PubMed ID: 28192026
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes and obesity: the twin epidemics.
    Smyth S; Heron A
    Nat Med; 2006 Jan; 12(1):75-80. PubMed ID: 16397575
    [No Abstract]   [Full Text] [Related]  

  • 38. What is diabetes distress and how can we measure it? A narrative review and conceptual model.
    Dennick K; Sturt J; Speight J
    J Diabetes Complications; 2017 May; 31(5):898-911. PubMed ID: 28274681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient explanations for non-attendance at type 2 diabetes self-management education: a qualitative study.
    Schwennesen N; Henriksen JE; Willaing I
    Scand J Caring Sci; 2016 Mar; 30(1):187-92. PubMed ID: 26058576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS).
    Gagliardino JJ; Aschner P; Baik SH; Chan J; Chantelot JM; Ilkova H; Ramachandran A;
    Diabetes Metab; 2012 Apr; 38(2):128-34. PubMed ID: 22019715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.